Leading research firm Taglich Brothers has initiated coverage on ALR Technologies, Inc. (OTCBB: ALRT) with a 12-month price target set at 50 cents.  Shares are trading today at 8 cents.  ALR maintains a relatively low profile in the investment community, but Taglich apparently sees some substantial upside based on their extensive analyst report. Read More

Research firm Taglich Brothers has initiated coverage on ALR Technologies, Inc. (OTCBB: ALRT); issuing a “Speculative Buy” rating and a $0.50 12-month price target on the healthcare technology company and developer of the Health-e-Connect (HeC) system.  HeC is an FDA-cleared Internet-based system from chronic disease management.  A scalable technology for a wide array of chronic diseases, HeC is initially being marketed by ALR Technologies as a solution Read More

ALR Technologies, Inc. (OTCBB: ALRT) products utilize internet based technologies to facilitate health care providers the ability to monitor their patient’s health and ensure adherence to health maintenance activities.

The Company’s Health-e-Connect (HeC) system is an internet based product initially intended for patients with diabetes and their health care providers to improve communication and monitoring of patients’ health Read More

Yesterday, ALR Technologies, Inc. (OTCBB:ALRT) hosted an investor call to discuss recent corporate developments and their proprietary Health-e-Connect (HeC) system with investors. The HeC system received 510(k) marketing clearance from the Food and Drug Administration in the fourth quarter of 2011. The company has been working towards market launch of the HeC system and, according to CEO Sidney Chan, expects to be generating sales of the system in 2012. Read More

ALR Technologies, Inc. (OTCBB:ALRT) is hosting an investor meeting/webinar after the markets close on Monday, March 19, 2012 at 4:30 PM EDT.  CEO and Chairman Sidney S. Chan will be providing an investor presentation to discuss corporate developments and product launch as well as conducting a question and answer session about the company and its Health-e-Connect (HeC) system for chronic disease management.  ALR Technologies received FDA 510(k) marketing clearance for their HeC system as a new solution for diabetes management in the fourth quarter of 2011. Read More

ALR Tech Meets With U.S. Business Leaders, Policymakers: Talks Focus on How Health-e-Connect Can Improve Patient Outcomes, Lower Healthcare Costs

ALR Technologies Inc. (OTCBB: ALRT) (the “Company”), a healthcare technology company, is pleased to provide shareholders with an update on corporate developments since receiving 510(k) clearance from the U.S. Food and Drug Administration for its Health-e-Connect (HeC) System for remote monitoring of patients in support of effective diabetes management Read More

ALR Technologies Inc. (OTCBB: ALRT), an innovative medical device company, offers a unique software solution aimed at improving patient adherence to care plans  in the diabetes industry working alongside companies like Abbott Laboratories (NYSE: ABT) and Bayer AG (PINK: BAYRY) that develop diabetes testing supplies. Read More

The International Diabetes Federation (IDF) is the umbrella organization of over 200 national diabetes associations in over 160 countries. It represents the interests of the growing number of people with diabetes and those at risk. The Federation has been leading the global diabetes community since 1950, and IDF’s mission is to promote diabetes care, prevention, and a cure worldwide. Read More

The New York Times published an article this past weekend titled, “Health Official Takes Parting Shot at Waste.”  Written by Robert Pear, the article focuses on commentary from Dr. Donald M. Berwick, the newly departed former administrator of the Centers for Medicare and Medicaid Services (CMS). Read More

Opportunity for Medicare to Reduce Millions in Costs
At the same time that the federal government seeks to cut Medicare spending, awareness is growing about a fraudulent practice around diabetes test strips that is running up program costs and putting the health of patients at risk. Read More